Free Trial

Amplifon (OTCMKTS:AMFPF) Shares Gap Down - Should You Sell?

Amplifon logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Shares gapped down pre-market from $14.09 to an open/last trade of $9.46, a sharp decline executed on very light volume (500 shares).
  • Amplifon is trading well below its 50‑day ($15.40) and 200‑day ($16.35) moving averages; it has a market cap of $2.13B and P/E of 16.89, but shows weak liquidity (current ratio 0.62, quick ratio 0.54) and a debt/equity of 1.14, suggesting both technical and balance‑sheet concerns.
  • Amplifon is a global leader in hearing care, operating a network of branded stores and partner outlets that provide diagnostics, personalized fittings, tinnitus management and aftercare.
  • MarketBeat previews top five stocks to own in May.

Amplifon S.p.A. (OTCMKTS:AMFPF - Get Free Report)'s stock price gapped down before the market opened on Thursday . The stock had previously closed at $14.0901, but opened at $9.46. Amplifon shares last traded at $9.46, with a volume of 500 shares.

Amplifon Stock Performance

The company has a current ratio of 0.62, a quick ratio of 0.54 and a debt-to-equity ratio of 1.14. The company's 50-day moving average price is $15.40 and its two-hundred day moving average price is $16.35. The company has a market cap of $2.13 billion, a P/E ratio of 16.89 and a beta of 0.46.

About Amplifon

(Get Free Report)

Amplifon is a global leader in hearing care, specializing in the retail and distribution of hearing aids, accessories and related services. The company offers a full suite of solutions including diagnostic hearing assessments, personalized hearing aid fittings, follow-up care, tinnitus management and hearing protection. Through its network of branded stores and partner outlets, Amplifon serves individuals across the full spectrum of hearing needs, from prevention and early detection to long-term aftercare.

Founded in Milan in 1950 by Algernon Charles Holland, Amplifon has grown from a single audiology centre into a multinational organization.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amplifon Right Now?

Before you consider Amplifon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amplifon wasn't on the list.

While Amplifon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines